Public interest in genetic screening is greater than ever. Guided by c
lues in the pedigree, clinicians can refer selected patients for an in
tensive genetic workup. Despite the limited number of DNA-based tests
and the dearth of effective preventive strategies, patients can benefi
t from existing risk assessment, surveillance, prevention, and counsel
ling.